BioCentury | May 16, 2019
Company News

May 16 Company Quick Takes: Iconic oncology deals; plus Zymeworks-GSK, Aimmune and more

...with Bison Capital Acquisition Corp. Wednesday. BioCentury Staff AR101, arc001, peanut allergy oral immunotherapy (oit) ICON-2 Kymriah, tisagenlecleucel (CTL019, cart-19, tisagenlecleucel-t) Aimmune Therapeutics Inc. Bison Capital Acquisition Corp. Exelixis...
Items per page:
1 - 1 of 1
BioCentury | May 16, 2019
Company News

May 16 Company Quick Takes: Iconic oncology deals; plus Zymeworks-GSK, Aimmune and more

...with Bison Capital Acquisition Corp. Wednesday. BioCentury Staff AR101, arc001, peanut allergy oral immunotherapy (oit) ICON-2 Kymriah, tisagenlecleucel (CTL019, cart-19, tisagenlecleucel-t) Aimmune Therapeutics Inc. Bison Capital Acquisition Corp. Exelixis...
Items per page:
1 - 1 of 1